{"gene":"SLC16A1","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1994,"finding":"Human MCT1/SLC16A1 cDNA was cloned and the protein shown to be 86% identical to hamster MCT1; the SLC16A1 locus was mapped to chromosome 1p13.2-p12 by PCR on human×rodent hybrid cell panels and fluorescence in situ hybridization.","method":"cDNA cloning, PCR on somatic cell hybrid panels, FISH","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct molecular cloning and chromosomal mapping with two orthogonal methods; foundational characterization paper","pmids":["7835905"],"is_preprint":false},{"year":2012,"finding":"Transgenic β-cell-specific overexpression of MCT1/SLC16A1 in mice is sufficient to cause exercise-induced hyperinsulinism (EIHI): isolated islets secreted insulin in response to pyruvate, fasting blood glucose was lowered in vivo, pyruvate challenge raised plasma insulin, and exercise failed to suppress insulin secretion—directly demonstrating that pyruvate entry via MCT1 triggers inappropriate insulin secretion and explaining the mechanism of EIHI-associated SLC16A1 promoter mutations.","method":"Doxycycline-inducible β-cell-specific transgenic mouse, ex vivo islet perifusion, in vivo pyruvate challenge, exercise protocol, blood glucose/insulin measurement","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — rigorous transgenic mouse model with multiple orthogonal functional readouts in vivo and ex vivo; directly tests and confirms the mechanistic hypothesis","pmids":["22522610"],"is_preprint":false},{"year":2014,"finding":"SLC16A1/MCT1 mediates H⁺-coupled transport of 5-oxoproline; the common polymorphism rs1049434 increases the Km for 5-oxoproline and lactate and increases the K0.5 for proton activation compared to wild-type, demonstrating a functional consequence of this variant on transporter kinetics. In T98G astrocyte-model cells, 5-oxoproline uptake is mediated solely by SLC16A1.","method":"Heterologous expression of wild-type and mutant SLC16A1, radiolabeled substrate transport assay, Michaelis-Menten kinetics, inhibitor studies in T98G cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro transport reconstitution with kinetic mutagenesis analysis; single lab but multiple orthogonal assays","pmids":["25371203"],"is_preprint":false},{"year":2016,"finding":"Atorvastatin is a non-competitive inhibitor of SLC16A1-mediated 5-oxoproline/lactate transport with an inhibition constant of ~40 µM, indicating it binds outside the substrate recognition site; however, the affinity is low enough that clinical interactions are unlikely.","method":"Heterologous SLC16A1 expression in mammalian cells and Xenopus oocytes, [³H]-5-oxoproline transport inhibition assay, Ki determination","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro transport assay with kinetic characterization; single lab, single method","pmids":["27341998"],"is_preprint":false},{"year":2017,"finding":"In human astrocytes (NHA cells), pH-dependent l-lactate uptake (Km ~0.64 mM) is mediated primarily by MCT1/SLC16A1, as shown by inhibition with the selective MCT1 inhibitors α-cyano-4-hydroxycinnamate and 5-oxoproline, and confirmed by MCT1 protein expression via immunohistochemistry.","method":"Radiolabeled l-lactate uptake assay, pharmacological inhibition, immunohistochemistry","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transport assay combined with pharmacological inhibitors and protein expression; single lab","pmids":["29154783"],"is_preprint":false},{"year":2019,"finding":"The circadian clock in retinal pigment epithelial cells regulates SLC16A1/MCT1 protein levels and apical lactate transport in a rhythmic manner; MCT1 protein (but not GLUT1) oscillated over time in ARPE-19 monolayers, and apical lactate concentrations were rhythmic and correlated with SLC16A1 mRNA expression. Photoreceptor outer segment (POS) incubation modulated SLC16A1 mRNA in a time-dependent fashion, suggesting the retina regulates RPE lactate transport via POS-RPE interaction.","method":"ARPE-19 monolayer culture, time-course protein and mRNA quantification, spectrophotometric lactate measurement, POS incubation experiment","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization and time-course functional measurements in a cell culture model; multiple methods but no genetic manipulation of the clock or SLC16A1","pmids":["31678436"],"is_preprint":false},{"year":2021,"finding":"PXR (Pregnane X Receptor) binds the SLC16A1 promoter and transcriptionally induces SLC16A1 expression in the presence of PXR agonists; pharmacological inhibition of SLC16A1 by BAY-8002 suppressed PXR-mediated sensitization of prostate cancer cells to afatinib and reduced intracellular afatinib accumulation, demonstrating that SLC16A1 mediates intracellular drug accumulation downstream of PXR.","method":"Stable PXR overexpression, ChIP assay (PXR binding to SLC16A1 promoter), pharmacological inhibition (BAY-8002), intracellular drug concentration measurement, cell viability assay","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP binding assay plus functional pharmacological inhibition in matched cell lines; single lab, two orthogonal methods","pmids":["34298852"],"is_preprint":false},{"year":2022,"finding":"OAT10 (SLC22A13) physically associates with MCT1/SLC16A1 in HEK293 cells, as identified by co-immunoprecipitation followed by LC-MS/MS. MCT1 knockdown increased OAT10-mediated uptake of β-hydroxybutyrate and nicotinate (shared substrates), but not orotate (OAT10-only substrate), indicating MCT1 acts as an efflux escape route for substrates taken up by nearby OAT10, functionally altering apparent OAT10 substrate selectivity.","method":"Co-immunoprecipitation / LC-MS/MS, siRNA knockdown, substrate uptake assay in Xenopus oocytes and HEK293 cells","journal":"Journal of pharmacological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with MS identification plus functional knockdown validation; single lab but two orthogonal methods","pmids":["35926947"],"is_preprint":false},{"year":2022,"finding":"Both MCT1/SLC16A1 and MCT4 contribute to pH-dependent l-lactate transport in hepatocellular carcinoma cells (HepG2, Huh-7); selective knockdown of MCT1 or MCT4 (but not MCT2) decreased l-lactate uptake, and kinetic analysis revealed biphasic uptake consistent with two distinct transporter systems operating simultaneously.","method":"siRNA knockdown, radiolabeled l-lactate uptake, pharmacological inhibitors, kinetic (Michaelis-Menten) analysis","journal":"Biopharmaceutics & drug disposition","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene knockdown combined with kinetic analysis and pharmacological inhibition; single lab, multiple orthogonal approaches","pmids":["36104287"],"is_preprint":false},{"year":2024,"finding":"ITCH E3 ubiquitin ligase inhibits alkaliptosis (pH-dependent cell death) in pancreatic ductal adenocarcinoma cells by blocking LATS1 ubiquitination, which in turn suppresses YAP1-dependent transcriptional activation of SLC16A1; SLC16A1 upregulation by YAP1 inhibits JTC801-induced alkaliptosis, establishing an ITCH→LATS1→YAP1→SLC16A1 signaling axis that controls intracellular pH homeostasis.","method":"Proteomics of nuclear fractions, shRNA knockdown of ITCH and pathway components, overexpression, cell viability and death assays, Western blot","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway placed by multi-step genetic epistasis with loss- and gain-of-function; single lab, mechanistic cascade validated by sequential knockdowns","pmids":["39179170"],"is_preprint":false},{"year":2024,"finding":"In HCC exosomes, SLC16A1-AS1 lncRNA enhances mRNA stabilization of SLC16A1 in macrophages by promoting interaction between the 3'UTR of SLC16A1 mRNA and the RNA-binding protein HNRNPA1; elevated SLC16A1 in macrophages accelerates lactate influx and activates c-Raf/ERK signaling to induce M2 polarization, establishing a non-canonical role of lactate transport via SLC16A1 in macrophage reprogramming.","method":"RNA immunoprecipitation, co-immunoprecipitation, mRNA stability assay, SLC16A1 knockdown/overexpression, lactate influx assay, c-Raf/ERK signaling readout","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway from HNRNPA1-mediated mRNA stabilization to lactate-ERK signaling validated by multiple methods; single lab","pmids":["39247822"],"is_preprint":false},{"year":2025,"finding":"TMPRSS11B modulates lactate import through SLC16A1 in pancreatic ductal adenocarcinoma cells: shRNA-mediated TMPRSS11B knockdown enhanced lactate import via SLC16A1 (measured by GFP/iLACCO1 lactate uptake assay), whereas TMPRSS11B overexpression dampened SLC16A1-driven lactate uptake; both effects depended on SLC16A1 and its chaperone Basigin (BSG), establishing TMPRSS11B as a negative regulator of BSG-supported SLC16A1 lactate transport.","method":"shRNA knockdown, overexpression, iLACCO1 fluorescent lactate biosensor assay, gene silencing epistasis, immunohistochemistry","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct lactate transport measurement with biosensor, epistasis validation; single lab, multiple cell lines","pmids":["40508207"],"is_preprint":false},{"year":2024,"finding":"SLC16A1 activates STAT3, which transcriptionally upregulates SLC7A11 in HNSCC cells; this SLC16A1→STAT3→SLC7A11 axis promotes ferroptosis resistance and tumor growth, as established by RNA sequencing of SLC16A1-knockdown cells, loss- and gain-of-function experiments, and xenograft assays.","method":"RNA sequencing, shRNA/siRNA knockdown, overexpression, in vitro and xenograft in vivo functional assays, Western blot, RT-qPCR","journal":"Oncology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway placed by transcriptomics plus sequential functional epistasis in vitro and in vivo; single lab","pmids":["42065048"],"is_preprint":false},{"year":2009,"finding":"miR-124 directly represses SLC16A1 expression: transfection of miR-124 in medulloblastoma cells reduced SLC16A1 mRNA and protein levels, and a luciferase reporter assay with the SLC16A1 3'UTR confirmed direct miR-124 binding; siRNA-mediated SLC16A1 knockdown independently induced cell death, suggesting SLC16A1 lactate-efflux function is required for cell survival during aerobic glycolysis.","method":"Transfection of miR-124, qRT-PCR, Western blot, 3'UTR luciferase reporter assay, siRNA knockdown, cell viability assay","journal":"Human pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase 3'UTR reporter plus protein-level knockdown confirmation and functional cell-death readout; single lab, multiple orthogonal methods","pmids":["19427019"],"is_preprint":false},{"year":2006,"finding":"MCT1/SLC16A1 inhibition (via lonidamine or exogenous lactate at acidic pH) lowered intracellular pH in neuroblastoma cells and correlated with reduced cell viability, and this mechanism of cell death was similar to that produced by the established MCT inhibitor α-cyano-4-OH-cinnamate, implicating MCT1-mediated lactate efflux as required for pH homeostasis and survival in neuroblastoma.","method":"Intracellular pH measurement (fluorescent dye), pharmacological MCT inhibition (lonidamine, α-cyano-4-OH-cinnamate), exogenous lactate treatment, cell viability assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct intracellular pH measurement combined with pharmacological inhibition and viability readout; single lab, multiple orthogonal assays","pmids":["17000864"],"is_preprint":false},{"year":2024,"finding":"In an orthotopic glioblastoma model, SLC16A1 silencing induced intracellular lactate accumulation, suppressed lactate-stimulated HCAR1/PI3K/AKT signaling, and promoted apoptosis both in vitro and in vivo, placing SLC16A1-mediated lactate export upstream of HCAR1/PI3K/AKT survival signaling.","method":"siRNA-mediated SLC16A1 knockdown, orthotopic rat GBM model, Western blot (PI3K/AKT pathway), apoptosis assay, histological analysis","journal":"Journal of nanobiotechnology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanistic pathway inference from knockdown phenotype; single lab, pathway placement indirect","pmids":["41840642"],"is_preprint":false},{"year":2025,"finding":"Conditional knockout of Mct1 (Slc16a1) specifically in annulus fibrosus and endplate cells of mice caused significant intervertebral disc degeneration with nucleus pulposus cell loss and delayed endplate maturation; endplate cells metabolized lactate and showed lactate-promoted H3K18 lactylation, demonstrating that MCT1-dependent lactate transport from nucleus pulposus cells to endplate cells mediates metabolic coupling essential for disc growth.","method":"Conditional knockout mouse (Slc16a1 Col2CreERT2), histology, spatial transcriptomics, metabolic assays, lactylation immunodetection","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct conditional knockout with multi-method phenotypic and metabolic characterization; preprint, single lab","pmids":[],"is_preprint":true},{"year":2024,"finding":"MCT1/SLC16A1 mediates direct mitochondrial import of lactate in the myocardium independently of the mitochondrial pyruvate carrier (MPC); isolated mitochondria from hearts lacking MCT1 showed a specific defect in mitochondrial lactate (but not pyruvate) metabolism, and cardiac MCT1 deletion caused rapid progression to heart failure under stress, establishing MCT1 as essential for mitochondrial lactate oxidation and cardiac energetics.","method":"13C stable isotope tracing, MPC genetic deletion, MCT1 cardiac-specific knockout, mitochondrial isolation and functional assays, cardiac function monitoring","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution with isolated mitochondria plus in vivo genetic model with multiple functional readouts; preprint, single lab","pmids":[],"is_preprint":true}],"current_model":"SLC16A1 encodes MCT1, a proton-linked monocarboxylate transporter that mediates pH-dependent import and export of lactate, pyruvate, ketone bodies, and 5-oxoproline across the plasma membrane; its expression in pancreatic β-cells is normally repressed (disallowed), and aberrant expression allows pyruvate entry to trigger inappropriate insulin secretion (exercise-induced hyperinsulinism); it physically associates with the chaperone Basigin and functionally couples with OAT10; it is regulated transcriptionally by PXR and YAP1 (downstream of the ITCH-LATS1 axis) and post-transcriptionally by miR-124; lactate efflux via SLC16A1 maintains intracellular pH homeostasis in glycolytic tumor cells, while lactate import supports mitochondrial oxidation in the heart and endplate metabolic coupling in the intervertebral disc; a common coding variant (rs1049434/D490E) alters substrate Km and proton affinity, and loss-of-function mutations cause recurrent ketoacidosis due to impaired ketone body utilization."},"narrative":{"mechanistic_narrative":"SLC16A1 encodes MCT1, a proton-coupled monocarboxylate transporter that moves lactate, ketone bodies, 5-oxoproline, and related substrates across membranes and thereby couples cellular metabolism to intracellular pH homeostasis [PMID:7835905, PMID:25371203, PMID:29154783]. Heterologous transport assays establish that MCT1 catalyzes H⁺-dependent uptake of 5-oxoproline and l-lactate with sub-millimolar affinity, and the common coding variant rs1049434 raises the Km for these substrates and the K0.5 for proton activation, demonstrating that single residues tune both substrate and proton handling [PMID:25371203, PMID:29154783]. Its directionality is context-dependent: in glycolytic tumor cells MCT1-mediated lactate efflux maintains intracellular pH and is required for survival, such that inhibition or silencing collapses pH and triggers cell death [PMID:19427019, PMID:17000864], whereas in cardiac muscle MCT1 imports lactate directly into mitochondria for oxidation independently of the mitochondrial pyruvate carrier, and in the intervertebral disc it transfers lactate from nucleus pulposus to endplate cells to support metabolic coupling and growth. β-cell-specific overexpression of MCT1 is sufficient to cause exercise-induced hyperinsulinism by allowing pyruvate entry to drive inappropriate insulin secretion, explaining the basis of EIHI-associated SLC16A1 promoter mutations [PMID:22522610]. MCT1 function is shaped by accessory and regulatory inputs: it physically associates with OAT10 (SLC22A13), acting as an efflux escape route that reshapes apparent OAT10 substrate selectivity [PMID:35926947], and it depends on the chaperone Basigin, whose support is negatively modulated by TMPRSS11B [PMID:40508207]. SLC16A1 expression is controlled transcriptionally by PXR and by an ITCH→LATS1→YAP1 axis that governs pH-dependent cell death, and post-transcriptionally by miR-124 repression and by HNRNPA1-dependent mRNA stabilization [PMID:34298852, PMID:39179170, PMID:19427019, PMID:39247822]. Downstream, MCT1-driven lactate flux engages STAT3/SLC7A11 and HCAR1/PI3K/AKT signaling in tumor cells and c-Raf/ERK-driven M2 macrophage polarization, linking lactate transport to proliferative and immunomodulatory programs [PMID:42065048, PMID:41840642, PMID:39247822].","teleology":[{"year":1994,"claim":"Established the molecular identity and chromosomal location of human MCT1, providing the cloned reagent needed for all subsequent mechanistic work.","evidence":"cDNA cloning, PCR on somatic cell hybrid panels, and FISH mapping to 1p13.2-p12","pmids":["7835905"],"confidence":"High","gaps":["No functional transport characterization in this study","No interactors or regulators identified"]},{"year":2006,"claim":"Tested whether MCT1-mediated lactate efflux is required for survival, showing that inhibition collapses intracellular pH and reduces viability in neuroblastoma.","evidence":"Intracellular pH measurement with pharmacological MCT inhibition and exogenous lactate in neuroblastoma cells","pmids":["17000864"],"confidence":"Medium","gaps":["Pharmacological inhibitors are not MCT1-specific","Does not distinguish MCT1 from other MCT isoforms genetically"]},{"year":2009,"claim":"Identified a post-transcriptional brake on SLC16A1 and reinforced that its lactate-efflux function supports glycolytic cell survival.","evidence":"miR-124 transfection, 3'UTR luciferase reporter, and siRNA knockdown with viability readout in medulloblastoma cells","pmids":["19427019"],"confidence":"Medium","gaps":["Single cell-type context","Physiological relevance of miR-124 regulation in vivo not established"]},{"year":2012,"claim":"Demonstrated causally that aberrant β-cell MCT1 expression triggers inappropriate insulin secretion, defining the disease mechanism of EIHI.","evidence":"Doxycycline-inducible β-cell-specific transgenic mouse with islet perifusion, pyruvate challenge, and exercise protocols","pmids":["22522610"],"confidence":"High","gaps":["Models overexpression rather than the human promoter mutation directly","Does not address regulation that normally represses β-cell expression"]},{"year":2014,"claim":"Defined MCT1 substrate kinetics and showed that the common rs1049434 variant alters both substrate Km and proton affinity, giving the variant a functional consequence.","evidence":"Heterologous expression of WT and mutant SLC16A1 with radiolabeled transport and Michaelis-Menten analysis","pmids":["25371203"],"confidence":"High","gaps":["In vitro kinetics; in vivo physiological impact of the variant not measured","Structural basis of altered proton coupling unknown"]},{"year":2017,"claim":"Confirmed MCT1 as the principal pH-dependent l-lactate transporter in human astrocytes using genetic-independent pharmacology and protein expression.","evidence":"Radiolabeled l-lactate uptake with selective inhibitors and immunohistochemistry in NHA cells","pmids":["29154783"],"confidence":"Medium","gaps":["No genetic knockdown confirmation","Single cell model"]},{"year":2019,"claim":"Showed that MCT1 protein and lactate transport are under circadian control in retinal pigment epithelium, linking transporter abundance to tissue rhythms.","evidence":"Time-course protein/mRNA quantification and lactate measurement in ARPE-19 monolayers with photoreceptor outer segment incubation","pmids":["31678436"],"confidence":"Medium","gaps":["No genetic manipulation of clock or SLC16A1","Mechanism linking clock to MCT1 protein levels not resolved"]},{"year":2021,"claim":"Placed SLC16A1 transcription under PXR control and showed it mediates intracellular drug accumulation, connecting the transporter to xenobiotic handling.","evidence":"PXR ChIP at the SLC16A1 promoter plus BAY-8002 inhibition and intracellular afatinib measurement in prostate cancer cells","pmids":["34298852"],"confidence":"Medium","gaps":["Single lab and cell context","Direct transport of afatinib by MCT1 versus indirect effect not fully resolved"]},{"year":2022,"claim":"Identified a physical and functional partnership with OAT10, revealing MCT1 as an efflux escape route that reshapes a neighbouring transporter's apparent selectivity.","evidence":"Reciprocal co-IP/LC-MS/MS and siRNA knockdown with substrate uptake in HEK293 and oocytes","pmids":["35926947"],"confidence":"Medium","gaps":["Physiological tissue where OAT10-MCT1 coupling operates not defined","Stoichiometry of the association unknown"]},{"year":2022,"claim":"Quantified the relative contribution of MCT1 versus MCT4 to hepatocellular carcinoma lactate transport, showing both operate as distinct kinetic systems.","evidence":"Isoform-selective siRNA knockdown with kinetic l-lactate uptake analysis in HepG2 and Huh-7 cells","pmids":["36104287"],"confidence":"Medium","gaps":["Does not resolve directionality (import vs export) in situ","Single tumor-type context"]},{"year":2024,"claim":"Positioned SLC16A1 as a transcriptional output of an ITCH→LATS1→YAP1 axis that controls pH-dependent cell death (alkaliptosis).","evidence":"Nuclear proteomics with sequential shRNA knockdown and gain-of-function epistasis in PDAC cells","pmids":["39179170"],"confidence":"Medium","gaps":["Direct YAP1 binding at the SLC16A1 locus not shown","Single lab"]},{"year":2024,"claim":"Revealed a non-canonical role in which exosomal lncRNA stabilizes SLC16A1 mRNA via HNRNPA1, driving lactate-ERK signaling and M2 macrophage polarization.","evidence":"RIP, mRNA stability assay, knockdown/overexpression, lactate influx and c-Raf/ERK readouts","pmids":["39247822"],"confidence":"Medium","gaps":["In vivo relevance of macrophage reprogramming not fully established","HNRNPA1-SLC16A1 mRNA interaction mapped in single context"]},{"year":2024,"claim":"Linked MCT1 lactate transport to a STAT3→SLC7A11 axis conferring ferroptosis resistance and tumor growth in HNSCC.","evidence":"RNA-seq of knockdown cells, loss/gain-of-function, and xenograft assays","pmids":["42065048"],"confidence":"Medium","gaps":["Mechanism by which MCT1 activates STAT3 not defined","Single tumor type"]},{"year":2024,"claim":"Placed MCT1-mediated lactate export upstream of HCAR1/PI3K/AKT survival signaling in glioblastoma.","evidence":"siRNA knockdown in orthotopic rat GBM model with PI3K/AKT and apoptosis readouts","pmids":["41840642"],"confidence":"Low","gaps":["Pathway placement indirect from knockdown phenotype","Single lab, no rescue experiment"]},{"year":2025,"claim":"Identified TMPRSS11B as a negative regulator of Basigin-supported MCT1 lactate uptake, adding a new layer of post-translational control.","evidence":"shRNA knockdown, overexpression, and iLACCO1 lactate biosensor epistasis in PDAC cells","pmids":["40508207"],"confidence":"Medium","gaps":["Molecular mechanism by which TMPRSS11B acts on BSG/MCT1 not defined","Single lab"]},{"year":2025,"claim":"Demonstrated in vivo that MCT1 mediates nucleus pulposus-to-endplate lactate transfer driving metabolic coupling and histone lactylation essential for disc growth.","evidence":"Conditional Slc16a1 knockout mouse with histology, spatial transcriptomics, and lactylation immunodetection (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint, single lab","Directionality of lactate flux inferred rather than directly traced"]},{"year":2024,"claim":"Established MCT1 as essential for mitochondrial lactate import and oxidation in the heart, independent of the mitochondrial pyruvate carrier.","evidence":"13C tracing, MPC and cardiac MCT1 deletion, isolated mitochondrial assays, and cardiac function monitoring (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint, single lab","Mechanism of MCT1 targeting to mitochondrial membrane not addressed"]},{"year":null,"claim":"How MCT1 directionality (import vs export) and substrate preference are set in a given tissue, and the structural basis of its proton coupling, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure or proton-coupling mechanism in the corpus","Determinants switching between lactate efflux (tumor pH homeostasis) and mitochondrial/import roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,4,7,8,17]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[2,4,16,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,7,11]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,4,8,16,17]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,4,7,8]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[9,13,14,15]}],"complexes":[],"partners":["SLC22A13","BSG","TMPRSS11B","HNRNPA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P53985","full_name":"Monocarboxylate transporter 1","aliases":["Solute carrier family 16 member 1"],"length_aa":500,"mass_kda":53.9,"function":"Bidirectional proton-coupled monocarboxylate transporter (PubMed:12946269, PubMed:32946811, PubMed:33333023). Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, acetate and the ketone bodies acetoacetate and beta-hydroxybutyrate, and thus contributes to the maintenance of intracellular pH (PubMed:12946269, PubMed:33333023). The transport direction is determined by the proton motive force and the concentration gradient of the substrate monocarboxylate. MCT1 is a major lactate exporter (By similarity). Plays a role in cellular responses to a high-fat diet by modulating the cellular levels of lactate and pyruvate that contribute to the regulation of central metabolic pathways and insulin secretion, with concomitant effects on plasma insulin levels and blood glucose homeostasis (By similarity). Facilitates the protonated monocarboxylate form of succinate export, that its transient protonation upon muscle cell acidification in exercising muscle and ischemic heart (PubMed:32946811). Functions via alternate outward- and inward-open conformation states. Protonation and deprotonation of 309-Asp is essential for the conformational transition (PubMed:33333023)","subcellular_location":"Cell membrane; Basolateral cell membrane; Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/P53985/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC16A1","classification":"Not Classified","n_dependent_lines":164,"n_total_lines":1208,"dependency_fraction":0.1357615894039735},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000155380","cell_line_id":"CID001312","localizations":[{"compartment":"membrane","grade":3},{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"BSG","stoichiometry":10.0},{"gene":"RAB11A","stoichiometry":4.0},{"gene":"CANX","stoichiometry":0.2},{"gene":"DNAJC2","stoichiometry":0.2},{"gene":"GNAI2;GNAI1;GNAO1","stoichiometry":0.2},{"gene":"NRAS","stoichiometry":0.2},{"gene":"STXBP3","stoichiometry":0.2},{"gene":"CD99","stoichiometry":0.2},{"gene":"GNA11","stoichiometry":0.2},{"gene":"EMB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001312","total_profiled":1310},"omim":[{"mim_id":"621073","title":"SORTING NEXIN 32; SNX32","url":"https://www.omim.org/entry/621073"},{"mim_id":"616095","title":"MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D","url":"https://www.omim.org/entry/616095"},{"mim_id":"613361","title":"SOLUTE CARRIER FAMILY 18, MEMBER B1; SLC18B1","url":"https://www.omim.org/entry/613361"},{"mim_id":"610021","title":"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7","url":"https://www.omim.org/entry/610021"},{"mim_id":"603877","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3","url":"https://www.omim.org/entry/603877"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Cell Junctions","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SLC16A1"},"hgnc":{"alias_symbol":["MCT","MCT1"],"prev_symbol":[]},"alphafold":{"accession":"P53985","domains":[{"cath_id":"1.20.1250.20","chopping":"12-199","consensus_level":"medium","plddt":94.1742,"start":12,"end":199},{"cath_id":"1.20.1250.20","chopping":"253-461","consensus_level":"medium","plddt":93.897,"start":253,"end":461}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53985","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53985-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53985-F1-predicted_aligned_error_v6.png","plddt_mean":83.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC16A1","jax_strain_url":"https://www.jax.org/strain/search?query=SLC16A1"},"sequence":{"accession":"P53985","fasta_url":"https://rest.uniprot.org/uniprotkb/P53985.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53985/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53985"}},"corpus_meta":[{"pmid":"19427019","id":"PMC_19427019","title":"miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.","date":"2009","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19427019","citation_count":143,"is_preprint":false},{"pmid":"17000864","id":"PMC_17000864","title":"The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17000864","citation_count":140,"is_preprint":false},{"pmid":"7835905","id":"PMC_7835905","title":"cDNA cloning of the human monocarboxylate transporter 1 and chromosomal localization of the SLC16A1 locus to 1p13.2-p12.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7835905","citation_count":81,"is_preprint":false},{"pmid":"32863950","id":"PMC_32863950","title":"LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32863950","citation_count":80,"is_preprint":false},{"pmid":"22522610","id":"PMC_22522610","title":"Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic β-cells leads to relative hyperinsulinism during exercise.","date":"2012","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22522610","citation_count":80,"is_preprint":false},{"pmid":"35167383","id":"PMC_35167383","title":"Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.","date":"2022","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/35167383","citation_count":60,"is_preprint":false},{"pmid":"25371203","id":"PMC_25371203","title":"Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25371203","citation_count":48,"is_preprint":false},{"pmid":"27751602","id":"PMC_27751602","title":"Heat stress-induced autophagy promotes lactate secretion in cultured immature boar Sertoli cells by inhibiting apoptosis and driving SLC2A3, LDHA, and SLC16A1 expression.","date":"2016","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/27751602","citation_count":39,"is_preprint":false},{"pmid":"26854723","id":"PMC_26854723","title":"Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4).","date":"2016","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/26854723","citation_count":38,"is_preprint":false},{"pmid":"32450050","id":"PMC_32450050","title":"Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32450050","citation_count":35,"is_preprint":false},{"pmid":"36584238","id":"PMC_36584238","title":"Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1).","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36584238","citation_count":30,"is_preprint":false},{"pmid":"31605138","id":"PMC_31605138","title":"Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31605138","citation_count":27,"is_preprint":false},{"pmid":"39247822","id":"PMC_39247822","title":"Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39247822","citation_count":23,"is_preprint":false},{"pmid":"32748357","id":"PMC_32748357","title":"SLC16A1-AS1 enhances radiosensitivity and represses cell proliferation and invasion by regulating the miR-301b-3p/CHD5 axis in hepatocellular carcinoma.","date":"2020","source":"Environmental science and pollution research international","url":"https://pubmed.ncbi.nlm.nih.gov/32748357","citation_count":20,"is_preprint":false},{"pmid":"33603467","id":"PMC_33603467","title":"LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33603467","citation_count":19,"is_preprint":false},{"pmid":"26608392","id":"PMC_26608392","title":"Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis.","date":"2015","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/26608392","citation_count":16,"is_preprint":false},{"pmid":"29154783","id":"PMC_29154783","title":"Involvement of monocarboxylate transporter 1 (SLC16A1) in the uptake of l-lactate in human astrocytes.","date":"2017","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29154783","citation_count":16,"is_preprint":false},{"pmid":"35316129","id":"PMC_35316129","title":"LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.","date":"2022","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35316129","citation_count":15,"is_preprint":false},{"pmid":"31678436","id":"PMC_31678436","title":"The circadian clock regulates RPE-mediated lactate transport via SLC16A1 (MCT1).","date":"2019","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/31678436","citation_count":15,"is_preprint":false},{"pmid":"34298852","id":"PMC_34298852","title":"PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34298852","citation_count":15,"is_preprint":false},{"pmid":"36104287","id":"PMC_36104287","title":"Involvement of SLC16A1/MCT1 and SLC16A3/MCT4 in l-lactate transport in the hepatocellular carcinoma cell line.","date":"2022","source":"Biopharmaceutics & drug disposition","url":"https://pubmed.ncbi.nlm.nih.gov/36104287","citation_count":14,"is_preprint":false},{"pmid":"19881260","id":"PMC_19881260","title":"Genetic variations in the MCT1 (SLC16A1) gene in the Chinese population of Singapore.","date":"2009","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/19881260","citation_count":13,"is_preprint":false},{"pmid":"31380330","id":"PMC_31380330","title":"A SLC16A1 Mutation in an Infant With Ketoacidosis and Neuroimaging Assessment: Expanding the Clinical Spectrum of MCT1 Deficiency.","date":"2019","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/31380330","citation_count":12,"is_preprint":false},{"pmid":"35372039","id":"PMC_35372039","title":"Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35372039","citation_count":11,"is_preprint":false},{"pmid":"33641091","id":"PMC_33641091","title":"Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.","date":"2021","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/33641091","citation_count":10,"is_preprint":false},{"pmid":"35293026","id":"PMC_35293026","title":"LncRNA SLC16A1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-411/MITD1 axis.","date":"2022","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/35293026","citation_count":9,"is_preprint":false},{"pmid":"33603475","id":"PMC_33603475","title":"LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33603475","citation_count":8,"is_preprint":false},{"pmid":"30177396","id":"PMC_30177396","title":"Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population.","date":"2018","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/30177396","citation_count":8,"is_preprint":false},{"pmid":"26595136","id":"PMC_26595136","title":"Variants of the Solute Carrier SLC16A1 Gene (MCT1) Associated With Metabolic Responses During a Long-Graded Test in Road Cyclists.","date":"2015","source":"Journal of strength and conditioning research","url":"https://pubmed.ncbi.nlm.nih.gov/26595136","citation_count":8,"is_preprint":false},{"pmid":"35829849","id":"PMC_35829849","title":"Analysis of the subcellular location of lncRNA SLC16A1-AS1 and its interaction with premature miR-5088-5p in oral squamous cell carcinoma.","date":"2022","source":"Odontology","url":"https://pubmed.ncbi.nlm.nih.gov/35829849","citation_count":7,"is_preprint":false},{"pmid":"31087708","id":"PMC_31087708","title":"Rno-miR-425-5p targets the DLST and SLC16A1 genes to reduce liver damage caused by excessive energy mobilization under cold stress.","date":"2019","source":"Journal of animal physiology and animal nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/31087708","citation_count":7,"is_preprint":false},{"pmid":"35926947","id":"PMC_35926947","title":"Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10.","date":"2022","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35926947","citation_count":7,"is_preprint":false},{"pmid":"38911368","id":"PMC_38911368","title":"Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38911368","citation_count":6,"is_preprint":false},{"pmid":"37307591","id":"PMC_37307591","title":"Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer.","date":"2023","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/37307591","citation_count":6,"is_preprint":false},{"pmid":"31510920","id":"PMC_31510920","title":"The use of the SLC16A1 gene as a potential marker to predict race performance in Arabian horses.","date":"2019","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31510920","citation_count":6,"is_preprint":false},{"pmid":"32972674","id":"PMC_32972674","title":"Variation in the SLC16A1 and the ACOX1 Genes Is Associated with Gallop Racing Performance in Arabian Horses.","date":"2020","source":"Journal of equine veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/32972674","citation_count":6,"is_preprint":false},{"pmid":"35609320","id":"PMC_35609320","title":"MicroRNA-1269 is downregulated in glioblastoma and its maturation is regulated by long non-coding RNA SLC16A1 Antisense RNA 1.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35609320","citation_count":5,"is_preprint":false},{"pmid":"39179170","id":"PMC_39179170","title":"ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation.","date":"2024","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39179170","citation_count":4,"is_preprint":false},{"pmid":"38539084","id":"PMC_38539084","title":"Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis.","date":"2024","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/38539084","citation_count":4,"is_preprint":false},{"pmid":"27341998","id":"PMC_27341998","title":"Interaction of atorvastatin with the human glial transporter SLC16A1.","date":"2016","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27341998","citation_count":4,"is_preprint":false},{"pmid":"38555465","id":"PMC_38555465","title":"Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38555465","citation_count":3,"is_preprint":false},{"pmid":"36654514","id":"PMC_36654514","title":"MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer.","date":"2023","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36654514","citation_count":3,"is_preprint":false},{"pmid":"40508207","id":"PMC_40508207","title":"Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Functional Link to Phenotype Heterogeneity.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40508207","citation_count":3,"is_preprint":false},{"pmid":"38515708","id":"PMC_38515708","title":"EP300 regulates the SLC16A1-AS1-AS1/TCF3 axis to promote lung cancer malignancies through the Wnt signaling pathway.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38515708","citation_count":3,"is_preprint":false},{"pmid":"35664312","id":"PMC_35664312","title":"Effect of SLC16A1 on Hepatic Glucose Metabolism in Newborn and Post-Weaned Holstein Bulls.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35664312","citation_count":2,"is_preprint":false},{"pmid":"38216723","id":"PMC_38216723","title":"The polymorphism T1470A of the SLC16A1 gene is associated with the lactate and ventilatory thresholds but not with fat oxidation capacity in young men.","date":"2024","source":"European journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38216723","citation_count":2,"is_preprint":false},{"pmid":"40302798","id":"PMC_40302798","title":"SLC16A1 Inhibits Ferroptosis and Promotes the Progression of Head and Neck Squamous Cell Carcinoma.","date":"2025","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40302798","citation_count":1,"is_preprint":false},{"pmid":"39659936","id":"PMC_39659936","title":"LncRNA SLC16A1-AS1 participates in the initiation and progression of colorectal cancer by regulating MAP3K9 expression through targeting miR-515-5p.","date":"2024","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39659936","citation_count":1,"is_preprint":false},{"pmid":"42065048","id":"PMC_42065048","title":"SLC16A1 Activates the STAT3/SLC7A11 Pathway to Mediate Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma.","date":"2026","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/42065048","citation_count":1,"is_preprint":false},{"pmid":"39787575","id":"PMC_39787575","title":"The association of SLC16A1 (MCT1) gene polymorphism with body composition changes during weight loss interventions: A randomized trial with sex-dependent analysis.","date":"2025","source":"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/39787575","citation_count":1,"is_preprint":false},{"pmid":"39715334","id":"PMC_39715334","title":"Hypoglycaemia following physical exercise in a patient with novel SLC16A1 variant.","date":"2025","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/39715334","citation_count":1,"is_preprint":false},{"pmid":"41840642","id":"PMC_41840642","title":"tLyP-1 peptide-modified MnO₂ co-delivering si-SLC16A1 and temozolomide synergistically suppresses glioblastoma via hypoxia modulation and metabolic stress.","date":"2026","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41840642","citation_count":0,"is_preprint":false},{"pmid":"41727188","id":"PMC_41727188","title":"LncRNA SLC16A1-AS1 cooperates with NSUN2 to stabilize GRP78 mRNA via m5C modification in gastric cancer.","date":"2026","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/41727188","citation_count":0,"is_preprint":false},{"pmid":"40464101","id":"PMC_40464101","title":"Genotype and Clinical Phenotype of Monocarboxylate Transporter 1 Deficiency in Three Palestinian Children: Report of Two Novel Variants in the SLC16A1 Gene.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40464101","citation_count":0,"is_preprint":false},{"pmid":"41300776","id":"PMC_41300776","title":"Muscle Oxygen Saturation Responses During Maximal and Submaximal Exercise According to SLC16A1 (MCT1) Gene Polymorphism in Long-Distance Runners: A Cross-Sectional Pilot Study.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/41300776","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.19.25324051","title":"Multi-level Regulatory Roles of Lactate Metabolism Gene Network in Oral Cancer: Machine Learning Insights","date":"2025-03-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.19.25324051","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.24.640004","title":"Lactate metabolic coupling between the endplates and nucleus pulposus via MCT1 is essential for intervertebral disc health","date":"2025-02-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.24.640004","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.16.638186","title":"Influence of gut microbiota on oral drug absorption and metabolism","date":"2025-02-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.16.638186","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.07.651641","title":"Nutritional Ketosis Attenuates Sucrose Bingeing-Induced Behavioral Deficits by Improving Synaptic Plasticity and Anti-Inflammatory Signalling in the Prefrontal Cortex","date":"2025-05-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.07.651641","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.07.617073","title":"Direct mitochondrial import of lactate supports resilient carbohydrate oxidation","date":"2024-10-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.07.617073","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.08.607157","title":"Pyruvate from bone marrow mesenchymal stem cells supports myeloma redox homeostasis and anabolism","date":"2024-08-09","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.08.607157","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34138,"output_tokens":5013,"usd":0.088804,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13388,"output_tokens":4910,"usd":0.094845,"stage2_stop_reason":"end_turn"},"total_usd":0.183649,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Human MCT1/SLC16A1 cDNA was cloned and the protein shown to be 86% identical to hamster MCT1; the SLC16A1 locus was mapped to chromosome 1p13.2-p12 by PCR on human×rodent hybrid cell panels and fluorescence in situ hybridization.\",\n      \"method\": \"cDNA cloning, PCR on somatic cell hybrid panels, FISH\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct molecular cloning and chromosomal mapping with two orthogonal methods; foundational characterization paper\",\n      \"pmids\": [\"7835905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Transgenic β-cell-specific overexpression of MCT1/SLC16A1 in mice is sufficient to cause exercise-induced hyperinsulinism (EIHI): isolated islets secreted insulin in response to pyruvate, fasting blood glucose was lowered in vivo, pyruvate challenge raised plasma insulin, and exercise failed to suppress insulin secretion—directly demonstrating that pyruvate entry via MCT1 triggers inappropriate insulin secretion and explaining the mechanism of EIHI-associated SLC16A1 promoter mutations.\",\n      \"method\": \"Doxycycline-inducible β-cell-specific transgenic mouse, ex vivo islet perifusion, in vivo pyruvate challenge, exercise protocol, blood glucose/insulin measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — rigorous transgenic mouse model with multiple orthogonal functional readouts in vivo and ex vivo; directly tests and confirms the mechanistic hypothesis\",\n      \"pmids\": [\"22522610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SLC16A1/MCT1 mediates H⁺-coupled transport of 5-oxoproline; the common polymorphism rs1049434 increases the Km for 5-oxoproline and lactate and increases the K0.5 for proton activation compared to wild-type, demonstrating a functional consequence of this variant on transporter kinetics. In T98G astrocyte-model cells, 5-oxoproline uptake is mediated solely by SLC16A1.\",\n      \"method\": \"Heterologous expression of wild-type and mutant SLC16A1, radiolabeled substrate transport assay, Michaelis-Menten kinetics, inhibitor studies in T98G cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro transport reconstitution with kinetic mutagenesis analysis; single lab but multiple orthogonal assays\",\n      \"pmids\": [\"25371203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Atorvastatin is a non-competitive inhibitor of SLC16A1-mediated 5-oxoproline/lactate transport with an inhibition constant of ~40 µM, indicating it binds outside the substrate recognition site; however, the affinity is low enough that clinical interactions are unlikely.\",\n      \"method\": \"Heterologous SLC16A1 expression in mammalian cells and Xenopus oocytes, [³H]-5-oxoproline transport inhibition assay, Ki determination\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro transport assay with kinetic characterization; single lab, single method\",\n      \"pmids\": [\"27341998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In human astrocytes (NHA cells), pH-dependent l-lactate uptake (Km ~0.64 mM) is mediated primarily by MCT1/SLC16A1, as shown by inhibition with the selective MCT1 inhibitors α-cyano-4-hydroxycinnamate and 5-oxoproline, and confirmed by MCT1 protein expression via immunohistochemistry.\",\n      \"method\": \"Radiolabeled l-lactate uptake assay, pharmacological inhibition, immunohistochemistry\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transport assay combined with pharmacological inhibitors and protein expression; single lab\",\n      \"pmids\": [\"29154783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The circadian clock in retinal pigment epithelial cells regulates SLC16A1/MCT1 protein levels and apical lactate transport in a rhythmic manner; MCT1 protein (but not GLUT1) oscillated over time in ARPE-19 monolayers, and apical lactate concentrations were rhythmic and correlated with SLC16A1 mRNA expression. Photoreceptor outer segment (POS) incubation modulated SLC16A1 mRNA in a time-dependent fashion, suggesting the retina regulates RPE lactate transport via POS-RPE interaction.\",\n      \"method\": \"ARPE-19 monolayer culture, time-course protein and mRNA quantification, spectrophotometric lactate measurement, POS incubation experiment\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization and time-course functional measurements in a cell culture model; multiple methods but no genetic manipulation of the clock or SLC16A1\",\n      \"pmids\": [\"31678436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PXR (Pregnane X Receptor) binds the SLC16A1 promoter and transcriptionally induces SLC16A1 expression in the presence of PXR agonists; pharmacological inhibition of SLC16A1 by BAY-8002 suppressed PXR-mediated sensitization of prostate cancer cells to afatinib and reduced intracellular afatinib accumulation, demonstrating that SLC16A1 mediates intracellular drug accumulation downstream of PXR.\",\n      \"method\": \"Stable PXR overexpression, ChIP assay (PXR binding to SLC16A1 promoter), pharmacological inhibition (BAY-8002), intracellular drug concentration measurement, cell viability assay\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP binding assay plus functional pharmacological inhibition in matched cell lines; single lab, two orthogonal methods\",\n      \"pmids\": [\"34298852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"OAT10 (SLC22A13) physically associates with MCT1/SLC16A1 in HEK293 cells, as identified by co-immunoprecipitation followed by LC-MS/MS. MCT1 knockdown increased OAT10-mediated uptake of β-hydroxybutyrate and nicotinate (shared substrates), but not orotate (OAT10-only substrate), indicating MCT1 acts as an efflux escape route for substrates taken up by nearby OAT10, functionally altering apparent OAT10 substrate selectivity.\",\n      \"method\": \"Co-immunoprecipitation / LC-MS/MS, siRNA knockdown, substrate uptake assay in Xenopus oocytes and HEK293 cells\",\n      \"journal\": \"Journal of pharmacological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with MS identification plus functional knockdown validation; single lab but two orthogonal methods\",\n      \"pmids\": [\"35926947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Both MCT1/SLC16A1 and MCT4 contribute to pH-dependent l-lactate transport in hepatocellular carcinoma cells (HepG2, Huh-7); selective knockdown of MCT1 or MCT4 (but not MCT2) decreased l-lactate uptake, and kinetic analysis revealed biphasic uptake consistent with two distinct transporter systems operating simultaneously.\",\n      \"method\": \"siRNA knockdown, radiolabeled l-lactate uptake, pharmacological inhibitors, kinetic (Michaelis-Menten) analysis\",\n      \"journal\": \"Biopharmaceutics & drug disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene knockdown combined with kinetic analysis and pharmacological inhibition; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"36104287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ITCH E3 ubiquitin ligase inhibits alkaliptosis (pH-dependent cell death) in pancreatic ductal adenocarcinoma cells by blocking LATS1 ubiquitination, which in turn suppresses YAP1-dependent transcriptional activation of SLC16A1; SLC16A1 upregulation by YAP1 inhibits JTC801-induced alkaliptosis, establishing an ITCH→LATS1→YAP1→SLC16A1 signaling axis that controls intracellular pH homeostasis.\",\n      \"method\": \"Proteomics of nuclear fractions, shRNA knockdown of ITCH and pathway components, overexpression, cell viability and death assays, Western blot\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway placed by multi-step genetic epistasis with loss- and gain-of-function; single lab, mechanistic cascade validated by sequential knockdowns\",\n      \"pmids\": [\"39179170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In HCC exosomes, SLC16A1-AS1 lncRNA enhances mRNA stabilization of SLC16A1 in macrophages by promoting interaction between the 3'UTR of SLC16A1 mRNA and the RNA-binding protein HNRNPA1; elevated SLC16A1 in macrophages accelerates lactate influx and activates c-Raf/ERK signaling to induce M2 polarization, establishing a non-canonical role of lactate transport via SLC16A1 in macrophage reprogramming.\",\n      \"method\": \"RNA immunoprecipitation, co-immunoprecipitation, mRNA stability assay, SLC16A1 knockdown/overexpression, lactate influx assay, c-Raf/ERK signaling readout\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway from HNRNPA1-mediated mRNA stabilization to lactate-ERK signaling validated by multiple methods; single lab\",\n      \"pmids\": [\"39247822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TMPRSS11B modulates lactate import through SLC16A1 in pancreatic ductal adenocarcinoma cells: shRNA-mediated TMPRSS11B knockdown enhanced lactate import via SLC16A1 (measured by GFP/iLACCO1 lactate uptake assay), whereas TMPRSS11B overexpression dampened SLC16A1-driven lactate uptake; both effects depended on SLC16A1 and its chaperone Basigin (BSG), establishing TMPRSS11B as a negative regulator of BSG-supported SLC16A1 lactate transport.\",\n      \"method\": \"shRNA knockdown, overexpression, iLACCO1 fluorescent lactate biosensor assay, gene silencing epistasis, immunohistochemistry\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct lactate transport measurement with biosensor, epistasis validation; single lab, multiple cell lines\",\n      \"pmids\": [\"40508207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SLC16A1 activates STAT3, which transcriptionally upregulates SLC7A11 in HNSCC cells; this SLC16A1→STAT3→SLC7A11 axis promotes ferroptosis resistance and tumor growth, as established by RNA sequencing of SLC16A1-knockdown cells, loss- and gain-of-function experiments, and xenograft assays.\",\n      \"method\": \"RNA sequencing, shRNA/siRNA knockdown, overexpression, in vitro and xenograft in vivo functional assays, Western blot, RT-qPCR\",\n      \"journal\": \"Oncology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway placed by transcriptomics plus sequential functional epistasis in vitro and in vivo; single lab\",\n      \"pmids\": [\"42065048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"miR-124 directly represses SLC16A1 expression: transfection of miR-124 in medulloblastoma cells reduced SLC16A1 mRNA and protein levels, and a luciferase reporter assay with the SLC16A1 3'UTR confirmed direct miR-124 binding; siRNA-mediated SLC16A1 knockdown independently induced cell death, suggesting SLC16A1 lactate-efflux function is required for cell survival during aerobic glycolysis.\",\n      \"method\": \"Transfection of miR-124, qRT-PCR, Western blot, 3'UTR luciferase reporter assay, siRNA knockdown, cell viability assay\",\n      \"journal\": \"Human pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase 3'UTR reporter plus protein-level knockdown confirmation and functional cell-death readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19427019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MCT1/SLC16A1 inhibition (via lonidamine or exogenous lactate at acidic pH) lowered intracellular pH in neuroblastoma cells and correlated with reduced cell viability, and this mechanism of cell death was similar to that produced by the established MCT inhibitor α-cyano-4-OH-cinnamate, implicating MCT1-mediated lactate efflux as required for pH homeostasis and survival in neuroblastoma.\",\n      \"method\": \"Intracellular pH measurement (fluorescent dye), pharmacological MCT inhibition (lonidamine, α-cyano-4-OH-cinnamate), exogenous lactate treatment, cell viability assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct intracellular pH measurement combined with pharmacological inhibition and viability readout; single lab, multiple orthogonal assays\",\n      \"pmids\": [\"17000864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In an orthotopic glioblastoma model, SLC16A1 silencing induced intracellular lactate accumulation, suppressed lactate-stimulated HCAR1/PI3K/AKT signaling, and promoted apoptosis both in vitro and in vivo, placing SLC16A1-mediated lactate export upstream of HCAR1/PI3K/AKT survival signaling.\",\n      \"method\": \"siRNA-mediated SLC16A1 knockdown, orthotopic rat GBM model, Western blot (PI3K/AKT pathway), apoptosis assay, histological analysis\",\n      \"journal\": \"Journal of nanobiotechnology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanistic pathway inference from knockdown phenotype; single lab, pathway placement indirect\",\n      \"pmids\": [\"41840642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Conditional knockout of Mct1 (Slc16a1) specifically in annulus fibrosus and endplate cells of mice caused significant intervertebral disc degeneration with nucleus pulposus cell loss and delayed endplate maturation; endplate cells metabolized lactate and showed lactate-promoted H3K18 lactylation, demonstrating that MCT1-dependent lactate transport from nucleus pulposus cells to endplate cells mediates metabolic coupling essential for disc growth.\",\n      \"method\": \"Conditional knockout mouse (Slc16a1 Col2CreERT2), histology, spatial transcriptomics, metabolic assays, lactylation immunodetection\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct conditional knockout with multi-method phenotypic and metabolic characterization; preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MCT1/SLC16A1 mediates direct mitochondrial import of lactate in the myocardium independently of the mitochondrial pyruvate carrier (MPC); isolated mitochondria from hearts lacking MCT1 showed a specific defect in mitochondrial lactate (but not pyruvate) metabolism, and cardiac MCT1 deletion caused rapid progression to heart failure under stress, establishing MCT1 as essential for mitochondrial lactate oxidation and cardiac energetics.\",\n      \"method\": \"13C stable isotope tracing, MPC genetic deletion, MCT1 cardiac-specific knockout, mitochondrial isolation and functional assays, cardiac function monitoring\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution with isolated mitochondria plus in vivo genetic model with multiple functional readouts; preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SLC16A1 encodes MCT1, a proton-linked monocarboxylate transporter that mediates pH-dependent import and export of lactate, pyruvate, ketone bodies, and 5-oxoproline across the plasma membrane; its expression in pancreatic β-cells is normally repressed (disallowed), and aberrant expression allows pyruvate entry to trigger inappropriate insulin secretion (exercise-induced hyperinsulinism); it physically associates with the chaperone Basigin and functionally couples with OAT10; it is regulated transcriptionally by PXR and YAP1 (downstream of the ITCH-LATS1 axis) and post-transcriptionally by miR-124; lactate efflux via SLC16A1 maintains intracellular pH homeostasis in glycolytic tumor cells, while lactate import supports mitochondrial oxidation in the heart and endplate metabolic coupling in the intervertebral disc; a common coding variant (rs1049434/D490E) alters substrate Km and proton affinity, and loss-of-function mutations cause recurrent ketoacidosis due to impaired ketone body utilization.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC16A1 encodes MCT1, a proton-coupled monocarboxylate transporter that moves lactate, ketone bodies, 5-oxoproline, and related substrates across membranes and thereby couples cellular metabolism to intracellular pH homeostasis [#0, #2, #4]. Heterologous transport assays establish that MCT1 catalyzes H\\u207a-dependent uptake of 5-oxoproline and l-lactate with sub-millimolar affinity, and the common coding variant rs1049434 raises the Km for these substrates and the K0.5 for proton activation, demonstrating that single residues tune both substrate and proton handling [#2, #4]. Its directionality is context-dependent: in glycolytic tumor cells MCT1-mediated lactate efflux maintains intracellular pH and is required for survival, such that inhibition or silencing collapses pH and triggers cell death [#13, #14], whereas in cardiac muscle MCT1 imports lactate directly into mitochondria for oxidation independently of the mitochondrial pyruvate carrier, and in the intervertebral disc it transfers lactate from nucleus pulposus to endplate cells to support metabolic coupling and growth [#16, #17]. \\u03b2-cell-specific overexpression of MCT1 is sufficient to cause exercise-induced hyperinsulinism by allowing pyruvate entry to drive inappropriate insulin secretion, explaining the basis of EIHI-associated SLC16A1 promoter mutations [#1]. MCT1 function is shaped by accessory and regulatory inputs: it physically associates with OAT10 (SLC22A13), acting as an efflux escape route that reshapes apparent OAT10 substrate selectivity [#7], and it depends on the chaperone Basigin, whose support is negatively modulated by TMPRSS11B [#11]. SLC16A1 expression is controlled transcriptionally by PXR and by an ITCH\\u2192LATS1\\u2192YAP1 axis that governs pH-dependent cell death, and post-transcriptionally by miR-124 repression and by HNRNPA1-dependent mRNA stabilization [#6, #9, #13, #10]. Downstream, MCT1-driven lactate flux engages STAT3/SLC7A11 and HCAR1/PI3K/AKT signaling in tumor cells and c-Raf/ERK-driven M2 macrophage polarization, linking lactate transport to proliferative and immunomodulatory programs [#12, #15, #10].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established the molecular identity and chromosomal location of human MCT1, providing the cloned reagent needed for all subsequent mechanistic work.\",\n      \"evidence\": \"cDNA cloning, PCR on somatic cell hybrid panels, and FISH mapping to 1p13.2-p12\",\n      \"pmids\": [\"7835905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional transport characterization in this study\", \"No interactors or regulators identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Tested whether MCT1-mediated lactate efflux is required for survival, showing that inhibition collapses intracellular pH and reduces viability in neuroblastoma.\",\n      \"evidence\": \"Intracellular pH measurement with pharmacological MCT inhibition and exogenous lactate in neuroblastoma cells\",\n      \"pmids\": [\"17000864\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pharmacological inhibitors are not MCT1-specific\", \"Does not distinguish MCT1 from other MCT isoforms genetically\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified a post-transcriptional brake on SLC16A1 and reinforced that its lactate-efflux function supports glycolytic cell survival.\",\n      \"evidence\": \"miR-124 transfection, 3'UTR luciferase reporter, and siRNA knockdown with viability readout in medulloblastoma cells\",\n      \"pmids\": [\"19427019\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell-type context\", \"Physiological relevance of miR-124 regulation in vivo not established\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated causally that aberrant \\u03b2-cell MCT1 expression triggers inappropriate insulin secretion, defining the disease mechanism of EIHI.\",\n      \"evidence\": \"Doxycycline-inducible \\u03b2-cell-specific transgenic mouse with islet perifusion, pyruvate challenge, and exercise protocols\",\n      \"pmids\": [\"22522610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Models overexpression rather than the human promoter mutation directly\", \"Does not address regulation that normally represses \\u03b2-cell expression\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined MCT1 substrate kinetics and showed that the common rs1049434 variant alters both substrate Km and proton affinity, giving the variant a functional consequence.\",\n      \"evidence\": \"Heterologous expression of WT and mutant SLC16A1 with radiolabeled transport and Michaelis-Menten analysis\",\n      \"pmids\": [\"25371203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro kinetics; in vivo physiological impact of the variant not measured\", \"Structural basis of altered proton coupling unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Confirmed MCT1 as the principal pH-dependent l-lactate transporter in human astrocytes using genetic-independent pharmacology and protein expression.\",\n      \"evidence\": \"Radiolabeled l-lactate uptake with selective inhibitors and immunohistochemistry in NHA cells\",\n      \"pmids\": [\"29154783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genetic knockdown confirmation\", \"Single cell model\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed that MCT1 protein and lactate transport are under circadian control in retinal pigment epithelium, linking transporter abundance to tissue rhythms.\",\n      \"evidence\": \"Time-course protein/mRNA quantification and lactate measurement in ARPE-19 monolayers with photoreceptor outer segment incubation\",\n      \"pmids\": [\"31678436\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genetic manipulation of clock or SLC16A1\", \"Mechanism linking clock to MCT1 protein levels not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed SLC16A1 transcription under PXR control and showed it mediates intracellular drug accumulation, connecting the transporter to xenobiotic handling.\",\n      \"evidence\": \"PXR ChIP at the SLC16A1 promoter plus BAY-8002 inhibition and intracellular afatinib measurement in prostate cancer cells\",\n      \"pmids\": [\"34298852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab and cell context\", \"Direct transport of afatinib by MCT1 versus indirect effect not fully resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a physical and functional partnership with OAT10, revealing MCT1 as an efflux escape route that reshapes a neighbouring transporter's apparent selectivity.\",\n      \"evidence\": \"Reciprocal co-IP/LC-MS/MS and siRNA knockdown with substrate uptake in HEK293 and oocytes\",\n      \"pmids\": [\"35926947\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological tissue where OAT10-MCT1 coupling operates not defined\", \"Stoichiometry of the association unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Quantified the relative contribution of MCT1 versus MCT4 to hepatocellular carcinoma lactate transport, showing both operate as distinct kinetic systems.\",\n      \"evidence\": \"Isoform-selective siRNA knockdown with kinetic l-lactate uptake analysis in HepG2 and Huh-7 cells\",\n      \"pmids\": [\"36104287\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not resolve directionality (import vs export) in situ\", \"Single tumor-type context\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Positioned SLC16A1 as a transcriptional output of an ITCH\\u2192LATS1\\u2192YAP1 axis that controls pH-dependent cell death (alkaliptosis).\",\n      \"evidence\": \"Nuclear proteomics with sequential shRNA knockdown and gain-of-function epistasis in PDAC cells\",\n      \"pmids\": [\"39179170\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct YAP1 binding at the SLC16A1 locus not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a non-canonical role in which exosomal lncRNA stabilizes SLC16A1 mRNA via HNRNPA1, driving lactate-ERK signaling and M2 macrophage polarization.\",\n      \"evidence\": \"RIP, mRNA stability assay, knockdown/overexpression, lactate influx and c-Raf/ERK readouts\",\n      \"pmids\": [\"39247822\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of macrophage reprogramming not fully established\", \"HNRNPA1-SLC16A1 mRNA interaction mapped in single context\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked MCT1 lactate transport to a STAT3\\u2192SLC7A11 axis conferring ferroptosis resistance and tumor growth in HNSCC.\",\n      \"evidence\": \"RNA-seq of knockdown cells, loss/gain-of-function, and xenograft assays\",\n      \"pmids\": [\"42065048\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which MCT1 activates STAT3 not defined\", \"Single tumor type\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed MCT1-mediated lactate export upstream of HCAR1/PI3K/AKT survival signaling in glioblastoma.\",\n      \"evidence\": \"siRNA knockdown in orthotopic rat GBM model with PI3K/AKT and apoptosis readouts\",\n      \"pmids\": [\"41840642\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pathway placement indirect from knockdown phenotype\", \"Single lab, no rescue experiment\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified TMPRSS11B as a negative regulator of Basigin-supported MCT1 lactate uptake, adding a new layer of post-translational control.\",\n      \"evidence\": \"shRNA knockdown, overexpression, and iLACCO1 lactate biosensor epistasis in PDAC cells\",\n      \"pmids\": [\"40508207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism by which TMPRSS11B acts on BSG/MCT1 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated in vivo that MCT1 mediates nucleus pulposus-to-endplate lactate transfer driving metabolic coupling and histone lactylation essential for disc growth.\",\n      \"evidence\": \"Conditional Slc16a1 knockout mouse with histology, spatial transcriptomics, and lactylation immunodetection (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Directionality of lactate flux inferred rather than directly traced\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established MCT1 as essential for mitochondrial lactate import and oxidation in the heart, independent of the mitochondrial pyruvate carrier.\",\n      \"evidence\": \"13C tracing, MPC and cardiac MCT1 deletion, isolated mitochondrial assays, and cardiac function monitoring (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Mechanism of MCT1 targeting to mitochondrial membrane not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MCT1 directionality (import vs export) and substrate preference are set in a given tissue, and the structural basis of its proton coupling, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure or proton-coupling mechanism in the corpus\", \"Determinants switching between lactate efflux (tumor pH homeostasis) and mitochondrial/import roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 4, 7, 8, 17]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [2, 4, 16, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 7, 11]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 4, 8, 16, 17]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 4, 7, 8]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [9, 13, 14, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SLC22A13\", \"BSG\", \"TMPRSS11B\", \"HNRNPA1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}